Friday, January 12, 2018 -- NewsThe FDA accepted Ortho Dermatologics' NDA filing for IDP-121 (tretinoin 0.05%) acne treatment in lotion form. If approved, it will be the first tretinoin product in lotion form rather than a gel or cream.Contributed Author: Valeant Pharmaceuticals International, Inc.Topics: Drug Development
Tuesday, December 26, 2017 -- Seysara (sarecycline) is a once-daily, oral, narrow spectrum tetracycline-derived antibiotic.
Wednesday, December 20, 2017 -- Combo of microneedling + trichloroacetic acid more effective than microneedling +/- platelet-rich plasma
Tuesday, December 19, 2017 -- Individuals categorized as overweight or obese had a significantly increased risk for malignant melanoma.
Thursday, December 14, 2017 -- by Kiyong Na, Sang Ho Oh, Sang Kyum Kim Acne keloidalis nuchae, a type of folliculitis involving the back of the neck, is common in black men, although rare cases have been reported in patients of other ethnicities. We analyzed the clinicopathological features of acne keloidalis nuchae in 17 Asians. Patients’ age at the time of presentation ranged from 20 to 69 years. Most patients experienced the disease over 2 years (range, 3 months–20 years); follow-up data were available for 11 (65%) patients (range, 2–95 months). Nine (53%) patients had comorbidities, but none had a history of other skin disease or a family history of acne keloidalis nuchae. Macroscopically, seven (41%) patients had multiple erythematous pustulopapular lesions, and 10
Thursday, December 14, 2017 -- Authors say measurement of serum homocysteine may be important for patient management
Monday, December 11, 2017 -- Recent research suggests that P. acnes, which is associated with acne vulgaris, is more likely to be present in the prostatic tissue of patients with the disease than in healthy individuals.
Monday, December 04, 2017 -- Recent research suggests that P. acnes, which is associated with acne vulgaris, is more likely to be present in the prostatic tissue of patients with the disease than in healthy individuals.
Monday, December 04, 2017 -- (MENAFN Editorial) MENLO PARK, Calif., Dec. 4, 2017 /PRNewswire/ --BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company developing products for the derma...
Friday, December 01, 2017 -- Body mass index is linked to malignant melanoma in men.
Wednesday, November 29, 2017 -- LOS ANGELES, Nov. 29, 2017 -- Truly Clear® today announced the launch of its flagship acne product, Truly Clear, an over the counter, antibacterial and antiseptic acne formula bar for treating acne of all skin types....
Sunday, November 12, 2017 -- (MedPage Today) -- Few studies to confirm risk, but guidelines discourage monotherapy with antimicrobials
Thursday, November 09, 2017 -- Addition of glycolic acid peel to microneedling linked to better scar improvement, skin texture
Tuesday, November 07, 2017 -- MORRISVILLE, N.C., Nov. 07, 2017 -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that it has agreed in principle to a business structure that would enable further development and advancement of...
Saturday, October 28, 2017 -- (MedPage Today) -- Biggest impact likely for patients with darker skin types
Friday, October 20, 2017 -- The skin solution is made with cannabidiols – natural compounds found in cannabis that have anti-inflammatory properties.
Saturday, October 14, 2017 -- (MedPage Today) -- Consent laws not clear with respect to minors and oral contraceptive pills
Thursday, October 12, 2017 -- Public healthcare provider plans to offload eight of their 77 U.S. hospitals, an effort expected to yield $900 million to $1 billion.
Tuesday, October 10, 2017 -- NEW HAVEN, Conn., Oct. 10, 2017 -- Melinta Therapeutics, a privately held commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, announced today that a Phase 1...
Thursday, October 05, 2017 -- - Phase 3 pivotal trials enrolled a total of 1,503 patients- Topline efficacy and safety results expected in first quarter of 2018 MENLO PARK, Calif., Oct. 05, 2017 -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical...